Pacira BioSciences, Inc.
For the period ended Nov 6, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 6, 2025 · Filed Nov 6, 2025
Use the contents to explore the available documents and sections.
PCRX$36.43+0.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Share Repurchase Program
Share Repurchase Program
During the third quarter of 2025, the company repurchased 2.0 million shares of its common stock through open market transactions for $50.0 million. At September 30, 2025, the company had $200.0 million remaining on its current share repurchase authorization, which expires December 31, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.